Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Personal Genome Machine (PGM™) Sequencer

Product Image
Product Description

The Personal Genome Machine (PGM™) Sequencer is a benchtop PostLight™ semiconductor-based platform that performs a sequencing run in approximately two hours. With a small benchtop footprint and a weight of 65 lbs (~30kg), low cost sequencing reagents, and simple touchscreen user interface, the Personal Genome Machine (PGM™) Sequencer brings next generation sequencing to every lab. The PGM™ Sequencer requires a Torrent Server for operation. The PGM™ includes a one year warranty on parts, labor, and travel for service personnel. A field service installation plan for the Personal Genome Machine System maximizes your productivity with installation of the Personal Genome Machine™ System by one of our certified field service engineers.

Features of the Personal Genome Machine™ Sequencing Platform Include:

• Scalable (1000x) semiconductor technology
• Natural biochemistry using inexpensive reagents
• Compatibility with all current library preparation methods
• Sequencing run times of about 2 hours
• A straightforward touchscreen user interface

The Personal Genome Machine™ advances Next-Generation sequencing to PostLight™ sequencing—the translation of chemical sequence information directly into digital form. PostLight™ technology means genetic sequencing is leveraged by the extreme scalability of semiconductor technology. Moore’s law is applied to genetic analysis.

Affordable Sequencing For Nearly Every Lab

Previous sequencing technologies have relied upon optical systems as bridges between the chemical and digital forms of sequence information. These systems have added tremendous costs to sequencers, relegating them to only the largest laboratories. By eliminating the need for the optical system, the Personal Genome Machine™ provides sequencing that is simpler, faster, more cost effective, and more scalable than any other technology available. With a small benchtop footprint and weight of 65 lbs (~30kg), low cost sequencing reagents, and a simple.

Product Personal Genome Machine (PGM™) Sequencer
Company Life Technologies
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Life Technologies
3175 Staley Road Grand Island, NY 14072 USA

Tel: +1.800.955.6288
Fax: +1.800.331.2286
Email: catalog@lifetech.com



Scientific News
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
HIV Structure Stabilized
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Four Newly-Identified Genes Could Improve Rice
A Japanese research team have applied a method used in human genetic analysis to rice and rapidly discovered four new genes that are potentially significant for agriculture. These findings could influence crop breeding and help combat food shortages caused by a growing population.
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Antibodies To Dengue May Alter Course Of Zika Virus Infection
Scientists at Emory Vaccine Center, in collaboration with investigators from Thailand, have found that people infected with dengue virus develop antibodies that cross-react with Zika virus.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!